Vimarsana
Biggest News Aggregation in the World

Page 17 - Three Years News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Three Years. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Three Years Today - Breaking & Trending Today

Rhythm Pharmaceuticals Presents Data from its Long-term Extension Study of Setmelanotide Showing Sustained and Deepened BMI Reduction in Patients with Hypothalamic Obesity at One Year at ObesityWeek® 2023 - Vimarsana News

Rhythm Pharmaceuticals Presents Data from its Long-term Extension Study of Setmelanotide Showing Sustained and Deepened BMI Reduction in Patients with Hypothalamic Obesity at One Year at ObesityWeek® 2023

-- Patients with hypothalamic obesity achieved mean BMI reduction of 25.5% at one year on setmelanotide treatment -- -- Three of 11 pediatric patients with hypothalamic obesity achieved normal...

By Light Awarded $4M Army National Guard Contract - Vimarsana News

By Light Awarded $4M Army National Guard Contract

- By Light to Deliver 702 GEN3 Recruiting Experiences and Three Years of After-Market Support -

Source: mykxlg.com
What's happening, Oct. 15, 2023 - Vimarsana News

What's happening, Oct. 15, 2023

SUNDAY

What's happening, Oct. 13, 2023 - Vimarsana News

What's happening, Oct. 13, 2023

FRIDAY

New 3-Year Extension Study Results Observed for Deucravacitinib Treatment of Plaque Psoriasis - Vimarsana News

New 3-Year Extension Study Results Observed for Deucravacitinib Treatment of Plaque Psoriasis

The new data on this drug’s effects on maintenance of clinical response indicates the strength of the treatment for individuals with the immune-mediated skin disease.